LSIA
HUMA icon

LaSalle St. Investment Advisors’s Humacyte HUMA Stock Holding History

LaSalle St. Investment Advisors’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.3K Buy
69,644
+728
+1% +$757 0.01% 407
2025
Q4 		$66K Buy
68,916
+1,600
+2% +$2.27K 0.01% 363
2025
Q3 		$117K Buy
67,316
+6,823
+11% +$13.4K 0.02% 348
2025
Q2 		$126K Buy
60,493
+18,194
+43% +$35K 0.03% 320
2025
Q1 		$72K Buy
+42,299
New +$159K 0.02% 313

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LaSalle St. Investment Advisors's HUMA Position: Q1 2026 in Review

LaSalle St. Investment Advisors increased its Humacyte (HUMA) stake by 1.1% in Q1 2026, buying an estimated $757 and bringing the position to 69,644 shares worth $42.3K. The position accounts for 0.01% of the portfolio, ranked #407.

LaSalle St. Investment Advisors first reported a position in HUMA in Q1 2025 and has held it in 5 quarters since. The position peaked at $126K in Q2 2025. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • LaSalle St. Investment Advisors held 69,644 shares of Humacyte worth $42.3K as of Q1 2026.
  • LaSalle St. Investment Advisors bought 728 Humacyte shares in Q1 2026, an estimated $757.
  • Humacyte made up 0.01% of LaSalle St. Investment Advisors's portfolio in Q1 2026, its #407 holding.
  • LaSalle St. Investment Advisors first reported a position in Humacyte in Q1 2025 and has held it in 5 quarters since.
  • LaSalle St. Investment Advisors's Humacyte position peaked at $126K in Q2 2025.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on LaSalle St. Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.